{"title":"Visual Analytic Methods for Hereditary Breast and Ovarian Cancer Risk Assessment","authors":"B. Drohan, G. Grinstein","doi":"10.1109/VIZ.2009.44","DOIUrl":null,"url":null,"abstract":"The identification and case management of those at risk high for Hereditary Breast and Ovarian Cancer (HBOC) involves the synthesis of data from self reported patient family history, quantitative risk model analysis, and current clinical standards of care. This paper describes an integrated interactive visualization and analysis approach for the presentation of these data that is suitable for large scale risk stratification. We describe this display of HBOC risk information integrated with a clinical decision support that is also potentially useful across other cancer syndromes.","PeriodicalId":315752,"journal":{"name":"2009 Second International Conference in Visualisation","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2009-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2009 Second International Conference in Visualisation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/VIZ.2009.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
The identification and case management of those at risk high for Hereditary Breast and Ovarian Cancer (HBOC) involves the synthesis of data from self reported patient family history, quantitative risk model analysis, and current clinical standards of care. This paper describes an integrated interactive visualization and analysis approach for the presentation of these data that is suitable for large scale risk stratification. We describe this display of HBOC risk information integrated with a clinical decision support that is also potentially useful across other cancer syndromes.